Topics

Roche undercuts price of Bayer cancer drug after winning FDA approval

07:00 EDT 16 Aug 2019 | PMLIVE

Both drugs highly effective in small subset of patients

Original Article: Roche undercuts price of Bayer cancer drug after winning FDA approval

NEXT ARTICLE

More From BioPortfolio on "Roche undercuts price of Bayer cancer drug after winning FDA approval"

Quick Search